Skip to content
10-K

Annual Report

TRACON Pharmaceuticals, Inc.

0000950170-24-026205

← back to feed
Filed
Mar 5, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 1, 2024 45.5M sh
Shares Diluted FY 2023 · Dec 31, 2023 32.75M sh
Shares Diluted FY 2023 · Dec 31, 2022 20.92M sh
Shares Diluted FY 2023 · Dec 31, 2021 17.25M sh
Operating Cash Flow FY 2023 · Dec 31, 2023 $3.68M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$26.24M
Operating Cash Flow FY 2023 · Dec 31, 2021 −$22.57M
Short Term Debt FY 2023 · Dec 31, 2023 $9.76M
Short Term Debt FY 2023 · Dec 31, 2022 $11.11M
Short Term Investments FY 2023 · Dec 31, 2023 $0
Cash And Equivalents FY 2023 · Dec 31, 2023 $8.56M
Cash And Equivalents FY 2023 · Dec 31, 2022 $17.43M
Stockholders Equity FY 2023 · Dec 31, 2023 −$809K
Stockholders Equity FY 2023 · Dec 31, 2022 −$7.15M
Stockholders Equity FY 2023 · Dec 31, 2021 $11.71M
Stockholders Equity FY 2023 · Dec 31, 2020 $25.07M
Current Liabilities FY 2023 · Dec 31, 2023 $10.18M
Current Liabilities FY 2023 · Dec 31, 2022 $22.37M
Current Assets FY 2023 · Dec 31, 2023 $9.09M
Current Assets FY 2023 · Dec 31, 2022 $18.23M
Total Assets FY 2023 · Dec 31, 2023 $10.11M
Total Assets FY 2023 · Dec 31, 2022 $19.47M
Eps Diluted FY 2023 · Dec 31, 2023 −$0.11
Eps Diluted FY 2023 · Dec 31, 2022 −$1.39
Eps Diluted FY 2023 · Dec 31, 2021 −$1.66
Eps Basic FY 2023 · Dec 31, 2023 −$0.11
Eps Basic FY 2023 · Dec 31, 2022 −$1.39
Eps Basic FY 2023 · Dec 31, 2021 −$1.66
Sga Expense FY 2023 · Dec 31, 2023 $6.67M
Sga Expense FY 2023 · Dec 31, 2022 $14.01M
Sga Expense FY 2023 · Dec 31, 2021 $17.55M
Rd Expense FY 2023 · Dec 31, 2023 $12.28M
Rd Expense FY 2023 · Dec 31, 2022 $13.89M
Rd Expense FY 2023 · Dec 31, 2021 $11.15M
Net Income FY 2023 · Dec 31, 2023 −$3.59M
Net Income FY 2023 · Dec 31, 2022 −$29.14M
Net Income FY 2023 · Dec 31, 2021 −$28.67M
Operating Income FY 2023 · Dec 31, 2023 −$9.27M
Operating Income FY 2023 · Dec 31, 2022 −$27.89M
Operating Income FY 2023 · Dec 31, 2021 −$28.35M
Revenue FY 2023 · Dec 31, 2023 $12.05M
Revenue FY 2023 · Dec 31, 2021 $346K
Capex FY 2023 · Dec 31, 2022 $17K
Capex FY 2023 · Dec 31, 2021 $48K